AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05118503 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Customized education
Description: Half of subjects will receive access to a customized app that will include brief educational videos that have been selected for each patient based on their medical history. These videos will address stroke etiology, underlying risk factors, and stroke prevention medications.
Study NCT05187130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: 60 patients in the mindfulness-based breathing and music therapy group were divided into subgroups of 5 participants each. Each 6-person group started by having participants complete the pretest State Anxiety Inventory, Beck Depression Inventory, and Psychological Well-Being Scale via Survey Monkey. Mindfulness-based breathing and music therapy was applied to each patient group in approximately 45-minute sessions per day. At the end of the session, participants re-filled the posttest State Anxiety Inventory, Work-Related Tension Scale, and Psychological Well-Being Scale. A total of 3 sessions were completed with an interval of two days.
Study NCT05118503 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Standard of care discharge education
Description: Half of subjects will be randomized to receive typical discharge education, per the institutional guidelines for standard of care education for stroke patients.
Study NCT04949477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexmedetomidine
Description: the patient will receive intranasal dexmedetomidine at a dose of 1 μg/kg to the patient 45 min. before the procedure.
Study NCT04949477 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: paracetamol
Description: the patient will receive paracetamol orally \[Rx paracetamol 250 mg/ml\] at a dose of 20 mg/kg given to the patient 45 min before the procedure by drinking.
Study NCT05255848 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin
Description: Patients will be given the same standard of care treatment plus nebulized heparin 5000IU every 8 hours started 24 hours after randomization, using a compressed air nebulizer, and will be continued for one week. In case of any complication, if the attending physician feels it necessary intervention treatment will be stopped
Study NCT06132594 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Conventional arthrocentesis followed by I-PRF injection
Description: An auriculotemporal nerve block using Mebacaine 0.5% was administered near the mandible's neck. The patient sat at a 45° angle with their head turned. The posterior entry point was 10 mm from the midtragus and 2 mm below the line, while the anterior entry point was marked 20 mm from the midtragus and 10 mm below the line. A biting block kept the mouth open. 2-3 ml of Ringer lactate was injected with an 18-gauge needle to enlarge the joint space. A second needle allowed the solution to flow freely. After lavaging the joint, 1 ml of I-PRF was injected into the upper joint space. Jaw manipulation was done to address adhesions and improve disc mobility.
Study NCT06132594 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 3d surgical guided Arthrocentesis followed by I-PRF injection
Description: Patients underwent arthrocentesis with Ringer lactate, followed by I-PRF injection in the TMJ's superior space using a CT-planned 3D-printed guide. Positioned at a 45° angle, patients were comfortably seated, and disinfection was performed. The patient-specific guide, fitting over maxillary teeth and the face, was employed unilaterally or bilaterally with a biting block for mouth opening maintenance. An 18-gauge needle administered 2-3 ml of Ringer lactate, widening the joint space, followed by a second needle allowing free solution flow (80-90 ml) to flush the superior joint space. Post-arthrocentesis, 1 ml of I-PRF was injected. To enhance joint mobility and free the disc, gentle manipulation of the lower jaw was performed after removing the needles and guide.
Study NCT05081518 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lu AG06466
Description: Lu AG06466 - capsule
Study NCT05081518 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo - capsule
Study NCT00692081 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social competence training
Description: 8 group sessions multi-modal social competence training, 2-4 hours each, 2 trainers, 6-10 participants
Study NCT00692081 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Special vocational training
Description: as provided in German special centres for vocational training
Study NCT05480085 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School-based extracurricular intervention focusing on screen media use and time spent with friends
Description: The intervention includes the following components:~1. Within each class parents will engage in two meetings combining education and parent-to-parent communication about 1) the children's leisure time activities, and 2) family and class screen time culture. Parents will engage in a short exercise focusing on screen media dilemmas conducted by the teacher in the beginning of 4th grade.~2. Children will engage in school hour workshops focusing on the class culture related to screen media use and leisure time activities.~3. Afterschool club personal will engage in mini actions learning program consisting of three workshops aimed to increase participation rate in the afterschool club.~4. Local stakeholders, e.g., parents, school- and afterschool club personal and others relevant to children's leisure time (e.g., sports clubs) will engage in workshops to adjust the predetermined intervention components (1-3 above) to fit their local context and to develop a local action plan.
Study NCT04849455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.2% ropivacaine local anesthetic continuous erector spinae plane block
Description: Treatment- continuous erector spinae block catheter followed by an infusion of ropivacaine 0.2% at 10ml automatic set bolus per 60 minute with 2ml/hr continuous infusion (12mls/hr total per catheter)
Study NCT04849455 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: 0.2% ropivacaine local anesthetic superficially taped continuous erector spinae plane block
Description: Placebo- Superficially placed (taped to the surface) erector spinae block catheter with a ropivacaine 0.2% infusion at 0.1ml /hr
Study NCT04849455 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spinal Morphine
Description: 200-300 mcg of spinal morphine
Study NCT04849455 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Spinal Morphine
Description: 200-300 mcg of spinal morphine
Study NCT06779526 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heartfulness Meditation
Description: Receiving an orientation session regarding the study, attending once weekly didactic sessions on Zoom for Heartfulness Meditation, and participating in morning and evening meditation for ten to fifteen minutes daily either by themselves or along with the trainer.
Study NCT06190132 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omega 3 fatty acid, gabapentin
Description: To study the effect of omega 3 fatty acids on uremic pruritus in prevalent hemodialysis patients versus the effect of gabapentin
Study NCT05443945 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Nasal Spray
Description: 3 sprays in each nostril 3 times per day
Study NCT05443945 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Nasal Spray
Description: 3 sprays in each nostril 3 times per day
Study NCT05794659 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: AST-201
Description: i.d. (3-week interval, 3 cycles in total)
Study NCT05794659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: 3-week interval, 6 cycles in total
Study NCT05794659 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Paclitaxel
Description: 3-week interval, 6 cycles in total
Study NCT05794659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: 3-week interval, 6 cycles in total
Study NCT05794659 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carboplatin
Description: 3-week interval, 6 cycles in total
Study NCT05794659 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: i.d. (3-week interval, 3 cycles in total)
Study NCT05794659 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: rhuGM-CSF(Granulocyte-Macrophage Colony-Stimulating Factor)
Description: i.d. (3-week interval, 3 cycles in total)
Study NCT05794659 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: rhuGM-CSF(Granulocyte-Macrophage Colony-Stimulating Factor)
Description: i.d. (3-week interval, 3 cycles in total)
Study NCT05842382 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Active Ingredient
Description: IV Vitamin C (12g/day)
Study NCT05842382 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: IV dextrose 5%
Study NCT05558683 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Randomized clinical trial.
Description: Our study will be a Randomized Clinical Trial. It will be held at the Aymara Abreu Physiotherapy Clinic center, with a maximum duration of 1 year. It will consist of two parts. In the first stage of the treatment we will carry out an initial assessment, and in the second stage a final assessment. After that, the corresponding data analysis will be carried out.
Study NCT04814108 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZN-c3
Description: ZN-c3 is an investigational drug.
Study NCT06652360 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Chemical Debridement
Description: The chemical debridement is a dehydrating agent in a gel shape that will dry out the woundbed and biofilm.
Study NCT06652360 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Curettage debridement
Description: The use of a currette will clean the wound bed. Debridement by mechanically removing the necrotic tissue and biofilm. This is performed confrom the standard of care standards.
Study NCT06452212 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: No investigational drug will be administered to participants in this study.
Study NCT04919395 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Clip device for Nexplanon Removal
Description: The clip device will be used to assist in the removal procedure to remove the Nexplanon implant from the subject.
Study NCT04919395 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care procedure
Description: The participants Nexplanon will be removed per standard of care.
Study NCT06673368 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NRCT-101SR, NRCT-202XR
Description: NRCT-101SR in combination with NRCT-202XR or NRCT-202XR alone
Study NCT06362291 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MRI-AI guided cognitive prostate targeted biopsy
Description: Before prostate biopsy, the MR images of patients in the AI-cTB group were uploaded to the AI software. Then the images with suspicious lesions highlighted by AI software were viewed by urologists. Biopsies were performed under the guidance of TRUS through the transrectal or transperineal route.
Study NCT06777511 — intervention group
Intervention type: DRUG
Intervention: 5-aminolevulinic acid (5-ALA)
Description: All patients who are recruited and enrolled into this study use topical 5- ALA, in combination with the light delivery device as part of their standard stoma management.
Study NCT06362291 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Routine cognitive prostate targeted biopsy
Description: Before prostate biopsy, the MR images and reports were viewed by urologists preceding the biopsy. Biopsies were performed under the guidance of TRUS through the transrectal or transperineal route.
Study NCT06622226 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONO-7018
Description: ONO-7018 tablet(s) are administered orally.
Study NCT06697106 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nonsteroidal anti-inflammatory drugs
Description: Patients will undergo direct vision internal urethrotomy (DVIU) plus nonsteroidal anti-inflammatory drugs (NSAID) for 3 weeks.
Study NCT06697106 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will undergo direct vision internal urethrotomy (DVIU) plus a placebo for 3 weeks.
Study NCT06698744 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UF-KURE-BCMA CAR T-cells
Description: Experimental anti-BCMA CAR T-cells manufactured with a proprietary ultrafast process. Patients will receive a single dose of CAR T-cells at one of three potential doses:~* Dose -1: 3x10\^6 cells~* Dose 1: 10x10\^6 cells~* Dose 2: 15x10\^6 cells
Study NCT06777511 — intervention group
Intervention type: DEVICE
Intervention: Photodynamic therapy (PDT)
Description: All patients who are recruited and enrolled into this study use topical 5- ALA, in combination with the light delivery device photodynamic therapy device as part of their standard stoma management.
Study NCT06778642 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Serratus Posterior Superior Intercostal Plane Block
Description: Patients undergoing Video-Assisted Thoracoscopic Surgery (VATS) will receive either a Serratus Posterior Superior Intercostal Plane Block (SPSIPB) with bupivacaine after induction and before the surgical procedure begins.
Study NCT06778642 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Serratus Anterior Plane Block
Description: Patients undergoing Video-Assisted Thoracoscopic Surgery (VATS) will receive either a Serratus Anterior Plane Block (SAPB) with bupivacaine after induction and before the surgical procedure begins.
Study NCT06778785 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Digital Intervention
Description: game-based digital intervention app
Study NCT06778785 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Intervention
Description: game-based digital intervention app
Study NCT06778785 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Health Education
Description: traditional health education app
Study NCT05353218 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intermediate cervical plexus block
Description: Intermediate cervical plexus block will be applied in transverse plane using posterior approach at C4.
Study NCT05353218 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Deep cervical plexus block
Description: Deep cervical plexus block will be appliedin transverse plane using anterior approach at C2-3-4.
Study NCT05560074 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Buzzy
Description: In the Buzzy® group, 30 seconds before the blood collection procedure and during the procedure, the Buzzy® device ist placed 3-5 cm above the area from where the blood would be taken by the PhD qualified nurse researcher
Study NCT05560074 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: DistrACTION® Cards
Description: In the DistrACTION® Cards group, picture cards containing various hidden pictures and patterns are used during blood collection by the PhD qualified nurse researcher
Study NCT05232344 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Estradiol / Progesterone
Description: Treatment with estradiol (Provames®, 3 mg morning and evening, or 6 mg per day) will start on the 1st or 2nd day of her period. This treatment is continued until the end of the study (discontinuation treatment after the blood test taken on Day 7). After ten days of minimum estradiol treatment (and up to 7 days later to be working days), vaginal progesterone treatment will start in the evening on Day 0 (400 mg, Progestan®, evening and morning, ie 800 mg per day).
Study NCT06698744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Patients will receive 3 days of intravenous (IV) cyclophosphamide 500 mg/m\^2 days -5 to -3 or -4 to -2 where day 0 is the day of CAR T-cell infusion.
Study NCT06698744 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Patients will receive 3 days of IV fludarabine 30 mg/m2 days -5 to -3 or -4 to -2 where day 0 is the day of CAR T-cell infusion.
Study NCT05232344 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sexual event
Description: A sexual intercourse (protected or not protected by condoms) will take place in a pre-defined order for each participant within one hour of the administration of the progesterone ovum on the evening of Day 2 and Day 6.
Study NCT05405855 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: eLIFEwithIBD
Description: eLIFEwithIBD program is a psychotherapeutic programme based on Acceptance, Mindfulness and Compassion for inflammatory bowel disease patients.
Study NCT05373186 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Euglycemic clamp with BC Combo THDB0207
Description: Administration of a single dose of BC Combo THDB0207 during an euglycemic clamp procedure
Study NCT05373186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Euglycemic clamp with Humalog® Mix25
Description: Administration of a single dose of Humalog® Mix25 during an euglycemic clamp procedure
Study NCT05373186 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Euglycemic clamp with Humalog® and Lantus®
Description: Simultaneous administration of Humalog® and Lantus® during an euglycemic clamp procedure
Study NCT05257668 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: High Intensity Interval Exercise Training
Description: High Intensity Interval Training Group
Study NCT05257668 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moderate Intensity Exercise Training
Description: Moderate Intensity Training Group
Study NCT06778785 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Personalization Algorithm
Description: a proprietary algorithm that adaptively adjust the treatment module and parameters to personalize the treatment regime
Study NCT06777693 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Unified Protocol
Description: The Unified Protocol group format involves 12 sessions focusing on goal setting and motivation, understanding emotions, mindful emotion awareness, cognitive flexibility, countering emotionat behaviours, understanding and confronting physical sensations, emotion exposure and relapse prevention.~The UP model directly approaches the patient\&#39;s emotion regulation by focusing on cognitive flexibility, exposure exercises, mindful awareness, acceptance, and other evidence-based therapeutic approaches known from cognitive-behavioural therapy (CBT), emotion-focused therapy (EFT) and mindfulness-based interventions.
Study NCT06116474 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Web-Based Physical Fitness Intervention
Description: The exercise program has been designed according to the progressive overload method. Therefore, the volume of the exercise program increased as the weeks progressed. Exercise videos were uploaded to YouTube on Mondays, Wednesdays and Fridays send to participants via a message group to follow the program. The videos featured the experts' explanations of the movements for each exercise.. The equipment that the participants should use in the training sessions was selected from the materials available at home (eg., use of water bottles instead of weight dumbbells). The exercise sessions is divided into 3 parts: warm-up (2-4 min. average), main part (14-19 min. average), cool-down (3-5 min. average). The warm-up includes movements to increase the heart rate and warm up the muscles to be worked on for that session. The main part of the exercise program also included rest breaks when the participants were asked to move and stretch.
Study NCT04953780 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calaspargase pegol-mknl
Description: Calaspargase pegol-mknl
Study NCT04778488 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Near-Infrared-Spectroscopy (NIRS)
Description: Placement of 2 NIRS optodes on the patients' forehead, measurement of NIRS during cardiac arrest and up to 72h post return of spontaneous circulation
Study NCT06377033 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral nudge
Description: Comparison of genetic rates among individuals for whom it may make a difference in their care across study arms.
Study NCT05951673 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Safe Space based life skills training program
Description: This is a Safe Space based life skills training program given to adolescent girls. Girls receive a 12 month long training on life skills such as negotiation skills, communication skills, sexual and reproductive health, gender-based violence and climate change.
Study NCT05951673 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Safe Space based life skills training program + Digital Skills
Description: This is a Safe Space based life skills training program given to adolescent girls complemented with a digital literacy training program. Girls receive a 12 month long training on life skills such as negotiation skills, communication skills, sexual and reproductive health, gender-based violence and climate change. The adolescent girls in this group also receive a digital literacy training program that covers content on word processing. database management and analysis, online marketing, online safety and programming.
Study NCT06043440 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxygen
Description: Active nocturnal oxygen concentrator
Study NCT00845689 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: NaCl 0,9 %